Sort
8,912 grants matching “sars cov 2”
Development of therapeutics for SARS-CoV-2 infection
$544,042Hiroaki Mitsuya · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
Scaling and Sustaining COVID-19 Vaccination through Meaningful Community Engagement and Care Coordination for Underserved Communities
$543,599Nicole A Stadnick · University Of California, San Diego · R01 · FY2024 · MD
COVID Immunophenotyping Study
$543,574Jane Hoyt Buckner · Benaroya Research Inst At Virginia Mason · R01 · FY2020 · AI
The Effects of Oxygen Therapy on Mouse Hepatitis Coronavirus Induced Pneumonia
$543,569Parizad Torabi-Parizi · National Heart, Lung, And Blood Institute · ZIA · FY2023 · HL
Coordinated regeneration of lung epithelial and endothelial compartments
$543,560Andrew Vaughan · University Of Pennsylvania · R01 · FY2024 · HL
Supplemental Citicoline Administration for Reduction of Lung Injury Efficacy Trial (SCARLET)
$543,218Elliott D Crouser · Ohio State University · U01 · FY2023 · AI
Longitudinal Epidemiology
$543,209Gabriel Alejandro De Erausquin · University Of Texas Hlth Science Center · U19 · FY2023 · AG
Armed nanobodies as anti-infectives and anti-tumor agents
$542,900Hao Wu · Boston Children'S Hospital · R01 · FY2025 · AI
Armed nanobodies as anti-infectives and anti-tumor agents
$542,900Hao Wu · Boston Children'S Hospital · R01 · FY2024 · AI
Mechanisms linking the plasminogen/fibrinogen axis to the pathogenesis of COVID-19
$542,806Matthew J. Flick · Univ Of North Carolina Chapel Hill · R01 · FY2023 · HL
Screening of novel compounds through the reversal of gene expression in idiopathic pulmonary fibrosis
$542,402Xiaopeng Li · Henry Ford Health + Michigan State University Health Sciences · R61 · FY2025 · HL
Determining the Fate of Transmembrane Proteins
$542,239Allan M Weissman · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
Lipid and Protein Effects on Monolayer Stability
$542,044Joseph Anthony Zasadzinski · University Of Minnesota · R01 · FY2021 · HL
Project 4
$541,971Ignacio E. Sanz · Emory University · P01 · FY2022 · AI
AI-based platform for predicting emerging vaccine-escape variants and designing mutation-proof antibodies
$541,935Guowei Wei · Michigan State University · R01 · FY2023 · AI
Systems biological assessment of B cell responses to vaccination
$541,840Scott Dexter Boyd · Stanford University · U19 · FY2023 · AI
Pathogenesis, Treatment and Prevention of Emerging Infectious Diseases
$541,331Clifford Lane · National Institute Of Allergy And Infectious Diseases · ZIA · FY2025 · AI
Severity and long-term health effects of COVID-19 among World Trade Center responders
$541,160Benjamin J Luft · State University New York Stony Brook · U01 · FY2024 · OH
Identification of senescent cell types
$541,140Laura Jane Niedernhofer · University Of Minnesota · P01 · FY2024 · AI
Phylogenetic modeling of viral transmission dynamics at the human-wildlife interface in Uganda
$540,590Krista Milich · Washington University · R01 · FY2023 · TW
Ultrafast Biophysical Studies of Biomolecules at the NIH
$540,564Philip Anfinrud · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2021 · DK
The mutational landscape of SARS-CoV-2 nucleocapsid protein
$540,265Peter Schuck · National Institute Of Biomedical Imaging And Bioengineering · ZIA · FY2025 · EB
AI-based platform for predicting emerging vaccine-escape variants and designing mutation-proof antibodies
$540,234Guowei Wei · Michigan State University · R01 · FY2022 · AI
Development of a Video-based Personal Protective Equipment Monitoring System
$540,210Randall S. Burd · Children'S Research Institute · R01 · FY2023 · EB
The Impacts of Mitigation Strategies to Prevent COVID-19 Transmission in American Indian Communities
$540,176Randall K. Q. Akee · National Bureau Of Economic Research · R01 · FY2022 · MD